Holen Sie sich die Stockscreener-App
15.19
0.20%
-0.03
Handel nachbörslich:
15.09
-0.10
-0.66%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AUPH?
Forum
Prognose
Aktiensplit
Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten
AUPH News | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
Aurinia (AUPH) Chief Legal Officer granted 115,541 performance stock units - Stock Titan
Aurinia Pharmaceuticals (AUPH) grants PSUs and stock options to CFO - Stock Titan
Aurinia (AUPH) COO receives 116,144 PSUs and 70,230 stock options - Stock Titan
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences - citybiz
Tranche Update on Aurinia Pharmaceuticals Inc.'s Equity Buyback Plan announced on February 15, 2024. - marketscreener.com
Why Aurinia Pharmaceuticals stock is surging Monday morning - MSN
Tangible book value per share of Aurinia Pharmaceuticals Inc. – FWB:IKAP - TradingView
Aurinia Pharmaceuticals stock (CA05156H1070): Q1 revenue beat and July earnings date in focus - AD HOC NEWS
Jefferies Upgrades Aurinia Pharmaceuticals (AUPH) - MSN
Behavioral Patterns of AUPH and Institutional Flows - Stock Traders Daily
Aurinia Pharmaceuticals (AUPH) Price Target Increased by 34.15% to 16.03 - MSN
Aurinia Pharmaceuticals' (NASDAQ:AUPH) Performance Raises Some Questions - simplywall.st
We Believe Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings Are A Poor Guide For Its Profitability - Yahoo Finance
Kezar Life Sciences stock (US49374L1008): Merger with Aurinia completes, shares cancelled - AD HOC NEWS
Aurinia Pharmaceuticals IncCommon Shares (NQ: AUPH - FinancialContent
Aurinia deal leaves Kezar (KZR) wholly owned as Tang Capital exits - Stock Titan
Aurinia Pharmaceuticals stock (CA05156H1070): Announces $6.955 Cash Acquisition of Kezar Life Scienc - AD HOC NEWS
AUPH stock sees biggest single-day drop in more than 9 months despite Q1 earnings beat – here’s what’s spooking investors - MSN
TradingKey - TradingKey
Kezar Life Sciences stock (US49374L1008): Aurinia completes $51.4M acquisition - AD HOC NEWS
Kezar Life Sciences (NASDAQ: KZR) COO disposes shares, options in Aurinia merger - Stock Titan
Aurinia deal cashes out Kezar (NASDAQ: KZR) CEO shares and options - Stock Titan
Kezar (KZR) director exits stake as Aurinia deal pays $6.955 plus CVRs - Stock Titan
Kezar (KZR) SVP tenders shares as Aurinia merger cancels stock options - Stock Titan
Morgan Stanley Smith Barney to sell 3.14M AUPH shares (AUPH) on 05/11/2026 - Stock Titan
AUPH (NASDAQ: AUPH) Proposed sale of 717,688 common shares - Stock Titan
500,503 AUPH shares listed for resale by Morgan Stanley (NASDAQ: AUPH) - Stock Titan
Aurinia Pharmaceuticals completes acquisition of Kezar Life Sciences By Investing.com - Investing.com Nigeria
Aurinia Pharmaceuticals completes acquisition of Kezar Life Sciences - Investing.com UK
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences - TipRanks
Kezar Life Sciences Acquired by Aurinia, Delisted From Nasdaq - TipRanks
Kezar Life Sciences acquired by Aurinia Pharma U.S.; Nasdaq delisting follows - Investing.com Nigeria
Aurinia acquires Kezar Life Sciences (NASDAQ: KZR) in cash-and-CVR deal - Stock Titan
Aurinia Pharmaceuticals (NASDAQ: AUPH) closes Kezar Life Sciences cash-and-CVR deal - Stock Titan
Aurinia (KZR) completes merger with Kezar — $6.955 per share plus CVR - Stock Titan
Aurinia to acquire Kezar Life Sciences (NASDAQ: KZR) in cash and CVR deal - Stock Titan
Aurinia Pharmaceuticals stock (CA05156H1070): Lupus drug developer eyes broader kidney disease marke - AD HOC NEWS
Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Moomoo
Aurinia Pharmaceuticals Inc. Just Beat EPS By 28%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Aurinia Pharmaceuticals (AUPH) Is Up 6.3% After Stronger Q1 LUPKYNIS-Driven Profitability Has The Bull Case Changed? - Sahm
Aurinia Pharmaceuticals (AUPH) Q1 EPS Of US$0.26 Tests Bullish Margin Narratives - Sahm
Aurinia Pharmaceuticals Sees 2026 Rev $315M-$325M >AUPH - Moomoo
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress - BioSpace
AUPH: Aurinia Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
AUPH Stock Sees Biggest Single-Day Drop In More Than 9 Months Despite Q1 Earnings Beat – Here’s What’s Spooking Investors - Stocktwits
Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Aurinia (NASDAQ: AUPH) boosts Q1 profit, buys back stock and moves to acquire Kezar - Stock Titan
Aurinia (NASDAQ: AUPH) boosts Q1 profit, cash flow and reaffirms 2026 outlook - Stock Titan
Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q1 EPS $0.25, Vs. FactSet Est of $0.20 - Moomoo
Canada's Aurinia Pharmaceuticals Q1 revenue rises 24% on LUPKYNIS demand - TradingView
Aurinia: Q1 Earnings Snapshot - marketscreener.com
(AUPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MSN Money - MSN
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):